Cargando…

Obesity affects graft function but not graft loss in kidney transplant recipients

OBJECTIVE: This study was performed to examine the suitability of transplantation in kidney transplant recipients (KTRs) with a high body mass index (BMI). METHODS: In total, 370 consecutive KTRs stratified according to the World Health Organization BMI categories were retrospectively analysed. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellini, Maria Irene, Koutroutsos, Kostas, Nananpragasam, Hannah, Deurloo, Emily, Galliford, Jack, Herbert, Paul Elliot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114276/
https://www.ncbi.nlm.nih.gov/pubmed/31939322
http://dx.doi.org/10.1177/0300060519895139
Descripción
Sumario:OBJECTIVE: This study was performed to examine the suitability of transplantation in kidney transplant recipients (KTRs) with a high body mass index (BMI). METHODS: In total, 370 consecutive KTRs stratified according to the World Health Organization BMI categories were retrospectively analysed. The estimated glomerular filtration rate (eGFR) was used to assess allograft function. RESULTS: The mean BMI was 26.2 kg/m(2). Among all patients, 148 (40.0%) were pre-obese, 47 (12.7%) were class I obese, 11 (3.0%) were class II obese, and 9 (2.4%) were class III obese. A linear trend for male sex and younger age was observed from the normal BMI group through the progressively higher groups. Overweight and obese KTRs had a significantly higher incidence of pre-transplant diabetes, but there was no difference in post-transplant new-onset hyperglycaemia. Obesity was not a significant risk factor for a lower eGFR at the 1-year follow-up, but it became significant at the 2- and 3-year follow-ups. Graft loss occurred in 28 patients, and 25 patients died during follow-up. No difference in all-cause allograft loss was found among the different BMI groups during follow-up. CONCLUSION: Obesity affects the eGFR in the long term. Allograft survival was lower, but not significantly.